TOPIC-001 / CHAPTER 08

Goodwill and impairment: a continuing test of the deal thesis

Goodwill does not prove synergy has been realised. It retains purchase-date premium not separately identified, while impairment testing continually challenges the operating capabilities and assumptions behind that premium.

TOPIC-001-CH08V1.0PUBLIC FULL CHAPTER2026.07.31

DECISIONS CHANGED

  1. 01

    Whether capabilities and synergy supporting the premium still exist

  2. 02

    Whether cash-generating units, budgets, parameters and actual outcomes remain consistent

  3. 03

    Whether deviation requires correction, revaluation, impairment, exit or capital reallocation

01

Return goodwill to the full deal chain

Price, identifiable net assets, intangibles, deferred tax, contingent consideration and non-controlling interests all affect goodwill. A large or small balance does not by itself judge the deal.

Commercial value, transaction design and accounting expression must remain separate. Goodwill is a purchase-date residual, not an independent package of synergy detached from facts.

02

Impairment is a cross-period hypothesis review

Current standards require at least annual testing of goodwill with the related cash-generating unit or group. The hard part is maintaining consistency among the deal thesis, allocation, monitoring level, unit boundary, budgets and actual results.

If boundaries and budget definitions move with outcomes, a mathematically correct model can still lose comparability. Forecasts must connect customers, orders, capacity, cash collection, capex, accountability and time.

03

Compensation does not automatically offset lost value

Contractual compensation, executable assets, economic loss and accounting presentation are four different layers. Missing a target may reflect temporary volatility or a failed thesis; received compensation may not cover time, organisational and cash loss.

Impairment returns to the unit containing goodwill and its recoverable amount. Contingent consideration, compensation, equity and profit treatment require fact-specific current-rule analysis.

04

Monitoring must precede year-end testing

Track customers, profit and cash, key people, licences, synergy and risk boundaries from closing, with clear ownership, resources, measures and triggers.

Reopen the capital decision immediately when assumptions repeatedly miss, synergy lacks an owner, parameters lack operating evidence or the team focuses only on avoiding impairment.

METHOD CONNECTION

MTH-0002 · Full M&A Capability ChainMTH-0006 · Full Value Bridge

PUBLIC SOURCES

ART-FMA-001 · Howard Hou: Financial Analysis in M&AMinistry of Finance: ASBE No. 8 — Impairment of AssetsCSRC: Regulatory Rules Application Guidance — Accounting No. 2CSRC: thematic inspection of goodwill impairment audit and valuation